Bellevue F (Lux) Bellevue Obesity Solutions B USD
WKNA0RPSP
AssetklasseAktien
464,79€-0,60€
30.12.2025 12:47-0,13%
464,79€-0,60€
30.12.2025 12:47-0,13%
Verkaufen
464,352VerkaufenStück: 80Kaufen
470,852KaufenStück: 80Eröffnung
461,414
Hoch
464,79
Tief
461,414
Fund seeks to achieve long-term capital growth by investing at least two-thirds of the net assets in a portfolio of carefully chosen shares and preference shares of companies whose business is directed towards the prevention and treatment of overweight or obesity and their secondary conditions or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. The Fund invests in biotech equities worldwide but mainly US.
Emittent
Waystone Management Company (Lux) SA
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
35,665
Gesamtkostenquote (TER)
2,17 %
Tracking Difference
1,3723
Replikation
-
Fondswährung
USD
Domizil
LU
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
547,88
NAV Datum
23.12.2025